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Pathogenic 
 
Mycobacterium
 
 reside inside vacuoles in their
host macrophages.  These vacuoles fail to fuse with lyso-
somes yet interact with early endosomes.  Glycoconjugates
released by the intracellular bacilli trafﬁc through the host
cell and are released through exocytosis.  These molecules
represent both antigens for immune recognition and
modulators of immune function.  The molecules play key
roles in the induction and maintenance of the granuloma,
a tissue response that limits bacterial spread yet ensures
persistence of the infection.
Introduction
 
Pathogenic 
 
Mycobacterium
 
 species are responsible for a wide
variety of human and animal ailments. In humans, the most
notable are tuberculosis (
 
Mycobacterium tuberculosis
 
) and
leprosy (
 
Mycobacterium leprae
 
), whereas 
 
Mycobacterium bovis
 
,
 
Mycobacterium avium
 
, and 
 
Mycobacterium marinum
 
 are
common pathogens of cattle, birds, and fish, respectively.
Despite the variety of hosts and diseases, all pathogenic
 
Mycobacterium
 
 spp. survive within their host phagocytes
(Fig. 1) and induce a localized, inflammatory response that is
granulomatous in nature.
 
Intracellular survival: remodeling of the endosome
 
The foundation of our appreciation of the cell biology of the
interplay between bacteria and phagocyte was laid by the
elegant studies of Philip D’Arcy Hart in the 1970’s who
demonstrated that 
 
M. tuberculosis
 
–containing phagosomes
fail to fuse with lysosomes after internalization by macro-
phages (Hart et al., 1972). Moreover, the absence of fusion
correlated with the viability of the infecting bacilli to the
extent that dead bacteria are delivered to the host cell’s lyso-
somes. Work on this phenomenon exploded in the 1990’s,
and our understanding of the biology of this cellular com-
partment is extensive, although the mechanism(s) behind its
generation and maintenance remain elusive.
Vacuoles containing pathogenic 
 
Mycobacterium
 
 spp. in
resting macrophages exhibit limited acidification (pH 6.2–
3) (Sturgill-Koszycki et al., 1994); however, contrary to early
suggestions the vacuoles are dynamic and retain the capacity
to fuse with other intracellular vesicles (Russell et al., 1996;
Sturgill-Koszycki et al., 1996). In essence, these bacilli
manipulate the endosomal system to arrest the maturation
of their compartment and retain access to the rapid recycling
endosome system of their host cell (Clemens and Horwitz,
1995; Clemens and Horwitz, 1996; Sturgill-Koszycki et al.,
1996). The restricted progression of 
 
Mycobacterium
 
-containing
vacuoles limits the hydrolytic capacity of the compartment,
facilitates access to nutrients internalized by the host cell,
and restricts the interface between the pathogen and the
antigen processing and presentation machinery of the
macrophage (Russell, 2001).
There has been a plethora of studies describing the aberrant
association or retention of early endosomal “markers” with
vacuoles containing virulent 
 
Mycobacterium
 
. In a notable
early study, Via et al. (1997) demonstrated that, in contrast
to vacuoles formed around inert particles, phagosomes con-
taining 
 
M. bovis
 
 BCG (bacille Calmette-Guérin) remained
associated with the small GTPase rab 5 that is known to
modulate the fusion behavior of early endosomes. More
recently, the same lab reported that vacuoles containing
 
Mycobacterium
 
 fail to acquire EEA 1, the rab 5- and PI
 
3
 
P-
binding protein, and show degradation of the early endosomal
v-SNARE cellubrevin (Fratti et al., 2001, 2002). The former
observation indicates that vacuole maturation might be ar-
rested through modulation of PI
 
3
 
-kinase activity. Intriguingly,
inhibitors of these enzymes, including antibodies against
VPS34, a class III PI
 
3
 
-kinase, produce a profile of phago-
some-associated proteins comparable to that observed for
 
Mycobacterium
 
 (Fratti et al., 2001)
 
.
 
 The degradation of vac-
uole-associated cellubrevin is also an interesting observation,
and the authors suggested that this could lead to diminished
delivery from both the TGN and the rapid recycling path-
way, which in turn could limit the maturation of the phago-
some. Data from previous studies show that 
 
Mycobacterium
 
-
containing vacuoles can access transferrin from the recycling
endosomal pathway (Clemens and Horwitz, 1996; Sturgill-
Koszycki et al., 1996; Ullrich et al., 1999) and that the
kinetics of transferrin flux through the 
 
Mycobacterium
 
-con-
taining vacuoles is comparable to that of uninfected cells. In
addition, cholera toxin B subunit bound to GM1 gan-
glioside on the surface of infected cells appears rapidly and
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Figure 2. Bone marrow–derived macrophages infected 72 h previously with M. tuberculosis, incubated in 10  g/ml biotinylated cholera toxin 
B for 15 min, washed, and placed in prewarmed medium for a 45 min chase period. The section was probed with streptavidin/antistreptavidin 
(anti–rabbit IgG 18 nm gold). Cholera toxin B can be detected in all of the bacterial vacuoles visible in this field, demonstrating the continued 
interaction between the host cell plasmalemma and the vacuoles harboring the bacilli. Reproduced from Russell et al. (1996).
Figure 1. Electron micrograph of an alveolar macrophage isolated 
by broncholavage from a tuberculosis patient in Malawi. The cell 
is heavily loaded with bacteria that reside within vacuoles. The 
vacuoles vary both in size and in the number of bacteria. This 
degree of heterogeneity in vacuole morphology is not observed 
in infections in culture.
 
uniformly in vacuoles containing 
 
M. tuberculosis
 
 (Fig. 2)
(Russell et al., 1996), supporting the contention that these
vacuoles retain access to early endosomes. Vesicular traffick-
ing from the TGN is more difficult to evaluate, although the
presence of cathepsin D in its proenzyme form has been de-
tected in 
 
M. avium
 
–containing vacuoles and is presumably
derived from the synthetic pathway and not fusion with ly-
sosomes (Ullrich et al., 1999). Nonetheless, the degradation
of cellubrevin could lead to modulation in vesicular traffick-
ing undetected by these assays.
Ferrari and Pieters described the acquisition and retention of
the actin-binding coat protein coronin I (TACO) by 
 
Mycobac-
terium
 
-containing phagosomes (Ferrari et al., 1999). Coronin I
had been shown previously to play a role in phagosome forma-
tion in 
 
Dictyostelium
 
 (Maniak et al., 1995) and through the he-
roic study of Morrissette et al. (1999) is also known to be asso-
ciated with latex bead phagosomes after internalization. Ferrari
and Pieters went on to demonstrate that the mouse coronin I
gene, on transfection into fibroblasts, facilitated infection of
these cells and suggested that the protein sequestered the bacte-
ria-containing vacuoles and blocked fusion with other intracel-
lular vesicles. However, examination of the original data sug-
gest that, although uptake was clearly different, survival rates
were affected minimally by the presence of coronin I (Ferrari et
al., 1999). The role of coronin I in regulating maturation of
 
Mycobacterium bovis
 
 BCG–containing phagosomes was also
examined by Schuller et al. (2001) who reported that, although 
 
 
Mycobacterium
 
 |
 
 Russell et al. 423
 
coronin I was involved in bacterial uptake, it did not remain as-
sociated with vacuoles containing viable bacilli. This is corrob-
orated by the immunofluorescence image of IgG bead phago-
somes that shows colocalization of coronin I and LAMP1 (Fig.
3), demonstrating that acquisition of LAMP1, i.e., phagosome
maturation, is unaffected by the presence of coronin I.
More recently, Gatfield and Pieters (2000) reported that
 
Mycobacterium
 
-containing vacuoles had a high cholesterol con-
tent and that depletion of cholesterol from the macrophages
before incubation with bacteria rendered the cells refractory to
infection. The authors suggested that cholesterol in the host
plasmalemma bound directly to the bacterium facilitating up-
take. However, the suggestion that the bacteria bind directly to
cholesterol is in conflict with the recent work of Peyron et al.
(2000) who demonstrated that the resistance of cholesterol-
depleted cells to infection was due to an effect on receptor sig-
naling rather than binding. Gatfield and Pieters (2000) re-
ported previously that 
 
M. tuberculosis
 
–infected macrophages
label intensely with filipin, a cholesterol marker (also shown in
Fig. 3). This may well reflect the fact that 
 
Mycobacterium
 
 resides
in a vacuole accessed readily by glycosphingolipid “rafts” that
are known to be cholesterol rich (Fig. 2) (Russell et al., 1996).
Kusner and colleagues noted that uptake of virulent 
 
M. tu-
berculosis
 
 via the complement receptor CR3 failed to induce
the increase in cytosolic Ca concentration observed on inter-
nalization of inert particles via the same receptor (Malik et
al., 2000). Artificial induction of a calcium flux with the ion-
ophore A23187 lead to increased fusion of the bacteria-con-
taining vacuoles with lysosomes, culminating in a reduction
in the number of viable bacilli. This transition correlated
with an increase in the amount of phosphorylated calcium/
calmodulin-dependent protein kinase II associated with the
cytosolic face of the phagosome (Malik et al., 2001).
All of the above studies show tantalizing snapshots of the bi-
ology of the bacterium-containing compartment, yet the mech-
anism(s) employed by the bacterium to achieve this degree of
control over their vacuoles remains to be defined. de Chastellier
and Thilo (1998) have implicated the hydrophobic nature of
the bacterial surface in the process, whereas the classic studies
by D’Arcy Hart suggested that ammonia production was respon-
sible for the absence of acidification (Gordon et al., 1980). More
recently, Fratti et al. (2000) demonstrated that beads coated
with the mycobacterial cell wall lipidoglycan, lipoarabinoman-
nan (LAM),* were internalized into phagosomes that showed
diminished fusion with lysosomes. Interestingly, this result was
not observed for particles coated in phosphatidylinositol man-
noside, which is a form of LAM without the elongated carbo-
hydrate chain. Whether this is a role of LAM in intact bacteria
and how the lipidoglycan mediates the reduced acquisition of
proteins such as EEA1 remains to be determined. Recent
breakthroughs in the application of emerging genetic tech-
niques to 
 
Mycobacterium 
 
may be useful in answering these
questions. Traditional screens that rely on bacterial death are
unlikely to work because the bacilli takes so long to die inside
macrophages that death could result from a broad range of de-
fects not connected to modulation of the vacuole. Nonetheless,
genetic screens based on enrichment protocols for bacteria un-
able to block progression down the endosomal continuum are
extremely attractive and offer an unbiased way of identifying
genes implicated in modulation of the host cell phagosome.
 
Shedding the fat
 
Despite the fact that vacuoles containing pathogenic 
 
Mycobac-
terium
 
 spp. fail to fuse with lysosomes, they fuse readily with
plasmalemma-derived, early endosomes, and therefore, mate-
rial released by the bacterium accesses both host cell lysosomes
and the cell surface. The release of pathogen-derived material
in the infected macrophage can be extreme, and both cell wall
lipids and bacterial proteins can be detected in the host cell
(Harth et al., 1994, 1996; Beatty et al., 2000; Beatty and Rus-
sell, 2000; Fischer et al., 2001; Neyrolles et al., 2001). The
consequences of this behavior are essentially twofold. First,
the macrophage is an antigen-presenting cell; therefore, mate-
rial released by the bacterium are potential antigens. Second,
the released material might modulate the function of both the
host cell and the surrounding tissue. The observation by Fratti
et al. (2000) on the properties of LAM suggests a role in vacu-
ole modulation, whereas other reports implicate cell wall com-
ponents in numerous aspects of immune modulation from
immune suppression to induction of proinflammatory re-
sponses, apoptosis, and granuloma formation.
We have observed that 
 
Mycobacterium
 
 labeled with Texas
red hydrazide after mild periodate treatment of live bacteria
released copious amounts of label inside the host macrophage
(Fig. 4). Solvent extraction of labeled bacteria followed by
thin layer chromatography indicated that the majority of fluo-
Figure 3. Immunofluorescent analysis of macrophage phagosomes 
formed around IgG beads (A/B) and M. tuberculosis (C/D). 
Fluorescent analysis of macrophage after uptake of IgG-coated 
beads (A and B) and infection with M. tuberculosis (C and D). 
Macrophages fixed 15 min after internalization of IgG-coated beads 
(arrows) probed with antibodies against LAMP1 (A) and coronin I 
(B). The labeling pattern shows strong colocalization of both LAMP1 
and coronin I around the early phagosome. C and D shows 
phase–contrast and fluorescence micrographs, respectively, of 
macrophages fixed and probed with filipin after overnight infection 
with M. tuberculosis. Filipin associates directly with cholesterol and 
shows the distribution of the lipid in the cell. There is a clear halo 
around the intracellular bacteria (arrows).
 
*Abbreviation used in this paper: LAM, lipoarabinomannan. 
424 The Journal of Cell Biology 
 
|
 
 
 
Volume 158, Number 3, 2002
 
rescent glycoconjugates released were lipid in nature (Beatty et
al., 2000). Although the arrangement of the lipids in the cell
wall is still a matter of considerable debate, there is consensus
concerning lipid identity (Besra and Chatterjee, 1994). Two-
dimensional thin layer chromatography analysis of released
lipids indicated that a heterogeneous mix of phospholipids,
glycolipids, and waxes is released. These lipids comprise phos-
phatidylinositol mono- and dimannosides (PIMs), phosphati-
dylglycerol and cardiolipin, phosphatidylethanolamine, treha-
lose mono- and dimycolates, and a 
 
M. bovis–
 
specific phenolic
glycolipid mycoside B (unpublished data). Cell fractionation
of infected macrophages by density gradient electrophoresis
demonstrated that the bacterial lipids tend to traffic in bulk
fashion through the cell and accumulate in a late endosome/
lysosome-like compartments (Beatty et al., 2000). Ultrastruc-
tural studies revealed multilamellar vesicles accumulating in
late infections by 
 
M. tuberculosis
 
, suggesting an impressive
overproduction of cell wall constituents. These compartments
also show an abundance of MHC class II molecules, suggest-
ing a possible connection with the antigen presentation ma-
chinery (Beatty and Russell, 2000; Beatty et al., 2001).
In terms of energy, continual lipid production is a very ex-
pensive behavior leading one to postulate that such a waste-
ful indulgence would need to be rewarded to be conserved
through evolution. There are many studies imbuing myco-
bacterial lipids with a range of mystical properties. This is
perhaps not surprising when one remembers that dead my-
cobacteria were the key ingredient in Freund’s Complete
Adjuvant. The obvious proinflammatory activity of these
lipids seems in contradiction to the covert phenotype of
many pathogens. Therefore, the properties of the released
material is best discussed in two discrete sections: one deal-
ing with their effects on acquired immunity and one dealing
with their proinflammatory properties.
 
Effects on adaptive immunity
 
The majority of molecules released by intracellular mycobac-
terium represent antigens recognized by the immune system.
Some of these antigens are proteins and some are lipids, yet
both can induce a cellular immune response capable of stim-
ulating T cells that demonstrate protective activity
 
.
 
 The
pathogen appears to cope with this conundrum through two
strategies: reducing the antigenicity of the infected macro-
phage to prevent its recognition and active modulation of
the local immune response to limit its efficacy at the site of
infection. With respect to reducing the host cell’s antigenic-
ity, antigen presentation by the infected macrophage is min-
imized by several mechanisms. First, the vacuoles in which
the bacteria reside do not lie within the antigen-sampling
continuum within the cell (Pancholi et al., 1993; Ullrich et
al., 2000). Although shortly after infection the vacuoles do
possess MHC class II molecules, these molecules are surface
derived and already peptide loaded and therefore limited in
their ability to sample new antigens. This strategy does not
work on macrophages activated with IFN
 
 
 
 before infection.
In these cells, the vacuoles acquire the MHC class II mole-
cule chaperone H2-M (mouse) or HLA-DM (human)
(Schaible et al., 1998; Ullrich et al., 2000). These chaper-
ones are responsible for removal of the invariant chain pep-
tide that blocks antigen loading, and the presence of H2-M/
HLA-DM signifies that the vacuoles are no longer seques-
tered outside the antigen-sampling machinery. The func-
tional significance of this transition was demonstrated ele-
gantly by Ramachandra et al. (2001) who showed that the
MHC molecules in 
 
Mycobacterium
 
-containing vacuoles in
activated macrophages are loaded with bacterial antigen and
are competent to induce T cell stimulation.
Infected cells show diminished expression of both classical
(MHC class I and class II) and nonpolymorphic (CD1) antigen
presentation and costimulatory molecules. The suppression is par-
tial, most groups reporting a 50–70% reduction in the surface ex-
pression of these molecules; however, this reduction does appear to
generate a measurable depression in T cell stimulation in in vitro
assays (Gercken et al., 1994; Wadee et al., 1995; Wojciechowski et
al., 1999; Giuliani et al., 2001). Lipidated moieties of mycobacte-
ria contribute to this diminution of antigen presentation and T
cell responsiveness. Noss et al. (2001) demonstrated that the 19-
kD lipoprotein down-regulated surface expression of MHC class
II molecules and reduced the antigen-presentation capacity of the
infected macrophage. Phenolic glycolipids bearing long chained
acyl tails suppress lymphoproliferation in vitro (Fournie et al.,
1989), and LAM interferes with IFN
 
 
 
-mediated activation of
macrophages (Sibley et al., 1988). All of these effects would aid a
persistent pathogen in maintaining its infection.
Figure 4. Release of labeled mycobacterial cell wall 
lipids into the macrophage endocytic network. (A) A 
live bone marrow–derived macrophage infected for 
24 h with Texas red hydrazide–labeled BCG were 
analyzed by fluorescence microscopy, with striking 
release of Texas red label from the bacterial phago-
some. (B) Infected macrophages were incubated with 
dextran-fluorescein for 1 h followed by a chase period 
of 3 h. Fluorescent label (Texas red) released from the 
bacteria permeated the host macrophage and colocal-
ized with dextran-fluorescein, revealing the accessibility 
of mycobacterial constituents to endocytic compart-
ments. Reproduced from Beatty et al. (2000). 
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However, there is some measure of conflict here because
in addition to confounding antigen presentation and the
adaptive immune response mycobacterial lipids may them-
selves be presented to lymphocytes in the context of CD1
molecules, nonpolymorphic MHC I–like antigen presenta-
tion molecules (Jullien et al., 1997). Most studies demon-
strating CD1-dependent recognition of mycobacterial lipids
have used human cells that express a more diverse set of
CD1 molecules than mouse cells. The acyl chains of LAM,
PIMs, and glycosylated mycolates can be loaded into the
deep hydrophobic binding pocket of CD1b in the acidic en-
vironment of late endosomes (Ernst et al., 1998). Once pre-
sented on the cell surface, lymphocytes recognize the lipids
in the context of CD1, responding with cytolytic activity
and lymphokine production. It has been speculated that an
infected macrophage, compromised in MHC class II–medi-
ated antigen presentation, might still be capable of present-
ing mycobacterial lipids in the context of CD1, thereby con-
tinuing to elicit some degree of protective lymphocyte
responses. Antibody-mediated blocking of CD1d results in
exacerbated bacterial growth and impaired expression of
macrophage-activating cytokines in mice (Szalay et al.,
1999). CD1d-deficient mice contain mycobacterial infec-
tions successfully; however, this demonstrates that CD1-
mediated events are not required for the development of a
protective immune response. These findings illustrate that
mycobacterial lipids fulfill multiple, apparently contradic-
tory roles with respect to the acquired immunity.
 
Active modulation in host responsiveness: 
whose granuloma is this anyway?
 
Granuloma formation is the defining characteristic of most
all mycobacterial infections. The tuberculosis granuloma in
humans is a highly organized structure that represents a bal-
ance between host and pathogen. For the host, the granu-
loma provides a focal point for the immune response, walls
off the infection, and thereby limits dissemination of bacte-
ria. For the pathogen, the proinflammatory environment of
the granuloma recruits potential host cells and maintains
lymphocytes at the periphery of the structure where mac-
rophage activation is likely to be less effective. The “poor”
distribution of lymphocytes is likely the result of the cytokine
microenvironments in the granuloma. The bacterial lipids re-
leased by the intracellular bacilli induce cytokines that, like
IL-6 (VanHeyningen et al., 1997), can be suppressive to T
cell proliferation, and the exocytosis of these lipids from in-
fected cells would extend the sphere of influence beyond the
confines of the host cell. Such a strategy would favor bacterial
persistence even in the face of a robust immune response.
The contribution of mycobacterial lipids to the formation
of the granuloma has been examined in several studies. For
example, cord factor (trehalose dimycolate) or LAM, when
added to particles and instilled into the lung, induce forma-
tion of epithelioid granulomas reminiscent of tubercles (Juf-
fermans et al., 2000; Lima et al., 2001). The proinflamma-
tory cytokines released by macrophages upon stimulation
with mycobacterial cell wall lipids are in very close agree-
ment with the expression profiles obtained more recently by
microarray analysis of monocytes exposed to either dead or
live 
 
M. tuberculosis
 
 (Ehrt et al., 2001) and would lead to the
recruitment of leukocytes to the site of infection (Rhoades et
al., 1995; Peters et al., 2001; Mendez-Samperio et al., 2002).
The lipidated cell wall constituents are recognized by Toll-
like receptors, a group of structurally related transmembrane
proteins that are “pattern” receptors, recognizing structural
motifs in microbial products (Brightbill et al., 1999; Under-
hill et al., 1999). Gram negative bacterial LPS is recognized by
TLR-4, whereas the majority of 
 
Mycobacterium
 
-derived moi-
eties stimulate cells via TLR-2. These include the structurally
related lipidoglycans LAM, PIM, and the 19-kD lipoprotein
(Underhill et al., 1999; Noss et al., 2001). Both PIM’s and
the 19-kd lipoprotein are released actively by bacteria inside
host macrophages, and PIMs are known to trigger cytokine
and chemokine induction in macrophages and dendritic cells
(unpublished data). The potent biological responses induced
by these molecules provide a clear justification of why such
apparently wasteful behavior would be sustained.
 
Concluding remarks
 
Persistence of infection is the hallmark of tuberculosis where
the infecting bacteria survive even in the face of a strong im-
mune response. The success of the bacterium is dependent on
its ability to manipulate both the host cell and the surrounding
tissues. The mechanisms behind these processes are just begin-
ning to emerge and appear to rely on the host’s capacity to rec-
ognize and respond to nonproteinaceous antigens and mole-
cules released by the bacteria. Research in this area promises to
be extremely informative across a range of disciplines beyond
the perverse eccentricities of the bug the Western world forgot.
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